These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9254595)
1. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595 [TBL] [Abstract][Full Text] [Related]
2. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320 [TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484 [TBL] [Abstract][Full Text] [Related]
4. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study. Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343 [TBL] [Abstract][Full Text] [Related]
5. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study. Bradshaw JM; Grucza RA; Ladbury JE; Waksman G Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054 [TBL] [Abstract][Full Text] [Related]
6. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains. de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159 [TBL] [Abstract][Full Text] [Related]
7. Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization. Henriques DA; Ladbury JE; Jackson RM Protein Sci; 2000 Oct; 9(10):1975-85. PubMed ID: 11106171 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078 [TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830 [TBL] [Abstract][Full Text] [Related]
10. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768 [TBL] [Abstract][Full Text] [Related]
11. Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization. DeLorbe JE; Clements JH; Teresk MG; Benfield AP; Plake HR; Millspaugh LE; Martin SF J Am Chem Soc; 2009 Nov; 131(46):16758-70. PubMed ID: 19886660 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs. Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902 [TBL] [Abstract][Full Text] [Related]
13. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems. Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160 [TBL] [Abstract][Full Text] [Related]
16. Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain. Liu WQ; Vidal M; Gresh N; Roques BP; Garbay C J Med Chem; 1999 Sep; 42(18):3737-41. PubMed ID: 10479306 [TBL] [Abstract][Full Text] [Related]
17. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978 [TBL] [Abstract][Full Text] [Related]
19. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain. Rojas M; Yao S; Donahue JP; Lin YZ Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774 [TBL] [Abstract][Full Text] [Related]
20. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides. Lee K; Zhang M; Liu H; Yang D; Burke TR J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]